Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.060
+0.170 (5.88%)
At close: Apr 28, 2026, 4:00 PM EDT
3.070
+0.010 (0.33%)
After-hours: Apr 28, 2026, 7:32 PM EDT

Editas Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-160.06-237.09-153.22-220.43-192.5
Upgrade
Depreciation & Amortization
5.285.816.066.345.05
Upgrade
Loss (Gain) From Sale of Assets
5.950.15---
Upgrade
Loss (Gain) From Sale of Investments
-0.9-5.79-4.82-0.721.66
Upgrade
Stock-Based Compensation
1021.4219.829.2943.4
Upgrade
Other Operating Activities
5.721.781.6--
Upgrade
Change in Accounts Receivable
1.09-6.08-5.04-4.885.78
Upgrade
Change in Accounts Payable
-2.89-2.29-1.494.37-1.14
Upgrade
Change in Unearned Revenue
-15.92-8.46--3.33-22.71
Upgrade
Change in Other Net Operating Assets
-13.5220.284.9412.02-3.35
Upgrade
Operating Cash Flow
-165.24-210.28-132.18-177.35-163.8
Upgrade
Capital Expenditures
-0.61-8.83-4.72-4.12-7.98
Upgrade
Sale of Property, Plant & Equipment
0.27--0.02-
Upgrade
Investment in Securities
139.01170.970.99118.17-46.49
Upgrade
Investing Cash Flow
138.67162.15-3.73114.07-54.47
Upgrade
Issuance of Common Stock
43.340.78118.041.28282.11
Upgrade
Other Financing Activities
-2.8755.24---
Upgrade
Financing Cash Flow
40.4756.03118.041.28282.11
Upgrade
Net Cash Flow
13.97.89-17.87-6263.84
Upgrade
Free Cash Flow
-165.85-219.11-136.9-181.47-171.78
Upgrade
Free Cash Flow Margin
-409.30%-678.06%-175.23%-920.59%-672.49%
Upgrade
Free Cash Flow Per Share
-1.87-2.66-1.80-2.64-2.54
Upgrade
Cash Interest Paid
2.13----
Upgrade
Levered Free Cash Flow
-71.48-122.46-87.81-102.27-85.55
Upgrade
Unlevered Free Cash Flow
-67.62-121.09-87.81-102.27-85.55
Upgrade
Change in Working Capital
-31.233.45-1.598.18-21.41
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.